Besides these membrane molecules, the cytokines that inhibit antitumor immune response or promote the transition of normal fibroblasts to CSFs, such as MIF, SPP1/OPN, could also be considered as therapeutic targets for cancer treatment (as proposed in Figure 7F). This evidence concerns the gene MIF and cancer.